Company: NDRA
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001213900-25-110887
Chunk: 27

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 1
Chunk 27
---
The Company has agreed to pay Lucid a commission
of up to 3.0% of the aggregate gross proceeds from any ATM Shares sold by Lucid and to provide Lucid with customary indemnification and
contribution rights, including for liabilities under the Securities Act. The Company also will reimburse Lucid for certain specified expenses
in connection with entering into and maintaining the ATM Agreement. The ATM Agreement contains customary representations and warranties
and conditions to the placements of the ATM Shares pursuant thereto.

14

Item 2. Management’s Discussion and Analysis
of Financial Condition and Results of Operations

Forward-Looking Statements

As used in this Quarterly Report on Form 10-Q
(this “Form 10-Q”), unless the context otherwise requires, the terms “we,” “us,” “our,”
“ENDRA” and the “Company” refer to ENDRA Life Sciences Inc., a Delaware corporation, and its direct and indirect
subsidiaries. The following discussion and analysis of our financial condition and results of operations should be read in conjunction
with our historical financial statements and related notes thereto in this Form 10-Q. This Form 10-Q contains forward-looking statements
within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as
amended, that are intended to be covered by the “safe harbor” created by those sections. Forward-looking statements, which
are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of
forward-looking terms such as “believe,” “expect,” “may,” “will,” “should,”
“could,” “would,” “seek,” “intend,” “plan,” “estimate,” “anticipate”
or other comparable terms. All statements other than statements of historical facts included in this Form 10-Q, including those regarding
our strategies, prospects, financial condition, operations, costs, plans and objectives, are forward-looking statements. Examples of forward-looking
statements include, among others, statements we make regarding expectations for revenues, cash flows and financial performance, the anticipated
results of our development efforts and the timing for receipt of required regulatory approvals and product launches. Forward-looking statements
are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and
assumptions regarding the future of our business, future plans and strategies, projections, anticipated events